The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.
Open accessAbstract
The resistance of parathyroid cells to 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) in uremic hyperparathyroidism is thought to be caused, in part, by a 1,25(OH)2D3 receptor (VDR) deficiency in the parathyroids. However, results of biochemical studies addressing VDR numbers in the parathyroids are controversial. Several studies have found VDR content to be decreased in the parathyroids of uremic patients and animals, while others have found no such decrease in the parathyroids of uremic animals. To clarify the role of VDR, we investigated VDR distribution in surgically-excised parathyroids obtained from chronic dialysis patients by immunohistochemistry. We classified the parathyroids as exhibiting nodular or diffuse hyperplasia. Our studies demonstrated a lower density of VDR in the parathyroids showing nodular hyperplasia than in those showing diffuse hyperplasia. Even in the parathyroids showing diffuse hyperplasia, nodule-forming areas were present; these areas were virtually negative for VDR staining. A significant negative correlation was found between VDR density and the weight of the parathyroids. These findings indicate that the conflicting results of biochemical studies may be caused by the heterogeneous distribution of VDR; the decreased VDR density in parathyroids may contribute to the progression of secondary hyperparathyroidism and to the proliferation of parathyroid cells that is seen in uremia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slatopolsky, E., Weerts, C., Thielan, J., Horst, R., Harter, H., & Martin, K. J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111639 · Cited by 684
Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.
Silver, J., Naveh-Many, T., Mayer, H., Schmelzer, H. J., & Popovtzer, M. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112714 · Cited by 536
Silver, J., Russell, J., & Sherwood, L. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4270 · Cited by 495
1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia
Szabo, A., Merke, J., Beier, E., Mall, G., & Ritz, E. (1989) · Kidney International · doi:10.1038/ki.1989.89 · Cited by 255
SUPPRESSION BY 1,25(OH)2D3OF TRANSCRIPTION OF THE PRE–PR0PARATHYR0ID HORMONE GENE
RUSSELL, J., LETTIERI, D., & SHERWOOD, L. M. (1986) · Endocrinology · doi:10.1210/endo-119-6-2864 · Cited by 244
CANTLEY, L. K., RUSSELL, J., LETTIERI, D., & SHERWOOD, L. M. (1985) · Endocrinology · doi:10.1210/endo-117-5-2114 · Cited by 231
Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremia
Merke, J., Hügel, U., Zlotkowski, A., Szabó, A., Bommer, J., Mall, G., & Ritz, E. (1987) · Kidney International · doi:10.1038/ki.1987.216 · Cited by 116
Pike, J. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43583-6 · Cited by 91
Nygren, P., Larsson, R. L., Johansson, H. E., Ljunghall, S., & Rastad, J. (1988) · Calcified Tissue International · doi:10.1007/bf02555137 · Cited by 89
Parathyroid Hormone Messenger Ribonucleic Acid: Effects of Calcium on Cellular Regulation in Vitro*
Heinrich, G., Kronenberg, H. M., Potts, J. T. J., & Habener, J. F. (1983) · Endocrinology · doi:10.1210/endo-112-2-449 · Cited by 51
Cited by
Bone metabolism and disease in chronic kidney disease
Eknoyan, G., Levin, A., & Levin, N. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00905-3 · Cited by 1,286
The parathyroid is a target organ for FGF23 in rats
Ben-Dov, I. Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R., Kuro-o, M., Mohammadi, M., Sirkis, R., Naveh-Many, T., & Silver, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32409 · Cited by 951
Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options
Cunningham, J., Locatelli, F., & Rodriguez, M. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06040710 · Cited by 646
Slatopolsky, E., Finch, J., Denda, M., Ritter, C., Zhong, M., Dusso, A., MacDonald, P. N., & Brown, A. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118701 · Cited by 511
Vitamin D receptor polymorphisms and diseases
Valdivielso, J. M., & Fernandez, E. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.02.016 · Cited by 510
Gogusev, J., Duchambon, P., Hory, B., Giovannini, M., Goureau, Y., Sarfati, E., & Drüeke, T. B. (1997) · Kidney International · doi:10.1038/ki.1997.41 · Cited by 493
Hyperphosphatemia of chronic kidney disease
Hruska, K. A., Mathew, S., Lund, R., Qiu, P., & Pratt, R. (2008) · Kidney International · doi:10.1038/ki.2008.130 · Cited by 438
Hruska, K. A., & Teitelbaum, S. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507203330307 · Cited by 404
Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Fukagawa, M., Yokoyama, K., Koiwa, F., Taniguchi, M., Shoji, T., Kazama, J. J., Komaba, H., Ando, R., Kakuta, T., Fujii, H., et al. (2013) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12058 · Cited by 402
Self-citationParicalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
Sprague, S. M., Llach, F., Amdahl, M., Taccetta, C., & Batlle, D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00878.x · Cited by 392
Pathogenesis of secondary hyperparathyroidism
Slatopolsky, E., Brown, A., & Dusso, A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07304.x · Cited by 309
Metabolic Bone Disease in Chronic Kidney Disease
Martin, K. J., & González, E. A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070771 · Cited by 288
Komaba, H., Goto, S., Fujii, H., Hamada, Y., Kobayashi, A., Shibuya, K., Tominaga, Y., Otsuki, N., Nibu, K.-I., Nakagawa, K., et al. (2010) · Kidney International · doi:10.1038/ki.2009.414 · Cited by 267
Self-citationMechanisms and Regulation of Intestinal Phosphate Absorption
Hernando, N., & Wagner, C. A. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170024 · Cited by 70
Metadata
- Authors
- Fukuda, N., Tanaka, H., Tominaga, Y., Fukagawa, M., Kurokawa, K., & Seino, Y.
- Venue
- Journal of Clinical Investigation
- Published
- 1993-09-01
- Volume
- 92
- Issue
- 3
- Pages
- 1436-1443
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1989640819
- Cited by
- 596
- References
- 11
- FWCI
- 18.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.